PHOTRONICS, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
Three Months and Six Months Ended May 4, 2014 and April 28, 2013
(unaudited)
(in thousands, except share amounts)
NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION
Photronics, Inc. and its subsidiaries ("Photronics" or “the Company") is one of the world's leading manufacturers of photomasks, which are high precision photographic quartz plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of semiconductors and flat panel displays ("FPDs"), and are used as masters to transfer circuit patterns onto semiconductor wafers and flat panel substrates during the fabrication of integrated circuits ("ICs") and a variety of FPDs and, to a lesser extent, other types of electrical and optical components. The Company currently operates principally from nine manufacturing facilities, two of which are located in Europe, three in Taiwan, one in Korea, and three in the United States.
On April 4, 2014, DNP Photomask Technology Taiwan Co., Ltd. (“DPTT”), a wholly owned subsidiary of Dai Nippon Printing Co., Ltd. (“DNP”), merged into Photronics Semiconductor Mask Corporation (“PSMC”), a wholly owned subsidiary of Photronics. All of the assets and liabilities of DPTT existing prior to the merger were assumed by the renamed surviving entity of the merger, Photronics DNP Mask Corporation (“PDMC”). Photronics and DNP own 50.01 percent and 49.99 percent of PDMC, respectively, and the results of DPTT are included in the condensed consolidated financial statements since the date of the acquisition.
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the interim period are not necessarily indicative of the results that may be expected for the fiscal year ending November 2, 2014. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended November 3, 2013.
NOTE 2 – ACQUISITION OF DNP PHOTOMASK TECHNOLOGY TAIWAN CO., LTD.
On April 4, 2014, DPTT merged into PSMC, the Company’s IC manufacturing subsidiary located in Taiwan, to form PDMC. Throughout this report the merger of DPTT into PSMC is referred to as the “DPTT Acquisition.” In connection with the DPTT Acquisition, the Company transferred consideration with a fair value of $41.0 million. The Company owns 50.01 percent of PDMC and includes its financial results in its consolidated financial statements, while DNP owns the remaining 49.99 percent of PDMC. The DPTT Acquisition was the result of the Company’s desire to combine the strengths in logic and memory photomask technologies of PSMC and DPTT in order to enhance its capability with customers in the region.
The DPTT Acquisition met the conditions of a business combination as defined by Accounting Standards Codification (“ASC”) 805 and, as such, is accounted for under ASC 805 using the acquisition method of accounting. ASC 805 defines the three elements of a business as Input, Process and Output. As a result of the DPTT Acquisition, Photronics acquired the machinery and equipment utilized in the processes to manufacture product, the building that houses the entire operation and the processes needed to manufacture the product, all previously owned by DPTT. The former DPTT employees hired by Photronics in connection with the acquisition brought with them the skills, experience and know-how necessary to provide the operational processes that, when applied to the acquired assets, represent processes being applied to inputs to create outputs. Having met all three elements of a business as defined in ASC 805, the Company determined that the DPTT Acquisition should be accounted for as a business acquisition.
The following table summarizes the provisional fair values of assets acquired and liabilities assumed of DPTT, the fair value of the noncontrolling interests and consideration for DPTT at the acquisition date. These provisional amounts could change as a result of the ultimate realization of the acquired net working capital.
Cash and cash equivalents
|
|
$
|
4,508
|
|
Accounts receivable (gross amount of $28,560, of which $500 is expected to be uncollectable)
|
|
|
28,060
|
|
Inventory
|
|
|
1,279
|
|
Deferred tax asset
|
|
|
9,787
|
|
Other current assets
|
|
|
11,517
|
|
Property, plant and equipment
|
|
|
95,431
|
|
Identifiable intangible assets
|
|
|
1,552
|
|
Other long-term assets
|
|
|
1,328
|
|
Accounts payable and accrued expenses
|
|
|
(32,410
|
)
|
Deferred tax liability
|
|
|
(3,042
|
)
|
Other long-term liabilities
|
|
|
(3,291
|
)
|
Total net assets acquired
|
|
|
114,719
|
|
Noncontrolling interests retained by DNP
|
|
|
57,348
|
|
|
|
|
57,371
|
|
Consideration – 49.99% of fair value of PSMC
|
|
|
40,999
|
|
Gain on acquisition
|
|
$
|
16,372
|
|
In addition to recording the fair values of the net assets acquired, the Company also recorded a gain on acquisition of $16.4 million in the condensed consolidated statement of income within other income (expense) in accordance with ASC 805 using the acquisition method of accounting. The gain on acquisition was primarily due to the difference between the market values of the acquired real estate and personal property exceeding the fair value of the consideration transferred. In addition, a deferred tax liability of $3.0 million was recorded in the opening balance sheet, which had the effect of reducing the gain on acquisition to $16.4 million. Prior to recording the gain, the Company reassessed whether it had correctly identified all of the assets acquired and all of the liabilities assumed. Additionally, the Company also reviewed the procedures used to measure the amounts of the identifiable assets acquired, liabilities assumed and consideration transferred.
The fair value of the consideration represents 49.99 percent of the fair value of PSMC, and is based on recent prices paid by the Company to acquire outstanding shares of PSMC (prior to the acquisition). As a result of the merger, the Company acquired the net assets of DPTT having a fair value of $114.7 million, less noncontrolling interests of $57.3 million retained by DNP, and transferred consideration with a fair value of $41.0 million, resulting in a gain of $16.4 million.
The acquisition date fair value of the property, plant and equipment of DPTT was $95.4 million, which was determined by utilizing the cost and, to a lesser extent, the market approach, based on an in-use premise of value. This fair value measurement is based on significant inputs that are not observable in the market and thus represents a fair value measurement categorized within Level 3 of the fair value hierarchy. Key assumptions include local and current construction replacement cost multipliers, amounts of ancillary replacement costs, physical deterioration, and economic and functional obsolescence to adjust the current replacement costs by, as well as the estimated economic lives of the assets.
Identifiable intangible assets acquired were primarily customer relationships, which represent the fair value of relationships and agreements DPTT had in place at the date of the merger, and had a fair value of $1.5 million at the acquisition date determined by using the multi-period excess earnings method and a twelve year estimated amortization period. The acquisition date fair value of the remainder of the identifiable assets acquired and liabilities assumed were equivalent to, or did not materially differ from their carrying values.
Acquisition costs related to the merger were $2.0 million and $2.5 million for the three and six month periods ended May 4, 2014, and are included in selling, general and administrative expense in the condensed consolidated statements of income.
Revenues and net income of PDMC included in the Company’s financial results from the April 4, 2014 acquisition date through May 4, 2014, are $13.1 million and $0.4 million respectively.
On a pro forma basis, revenues, earnings and earnings per share of Photronics, Inc. and subsidiaries, calculated as though the merger had occurred as of the beginning of the earliest period presented, for the three and six month periods ended May 4, 2014 and April 28, 2013, are presented below. The pro forma earnings for the three and six month periods ended May 4, 2014, were adjusted to exclude $2.0 million and $2.5 million of the above mentioned nonrecurring acquisition related costs and the gain on acquisition of $16.4 million. Other material nonrecurring pro forma adjustments made to arrive at the below earnings amounts included the add back of additional depreciation recorded against DPTT long-lived assets of $3.4 million and $3.3 million for the three month periods ended May 4, 2014 and April 28, 2013, respectively, and $6.6 million and $6.4 million for the six month periods ended May 4, 2014 and April 28, 2013, respectively. The pro forma information presented does not purport to represent results that would have been achieved had the merger occurred as of the beginning of the earliest period presented, or to be indicative of the Company’s future financial performance.
|
|
Three Months Ended
|
|
|
Six Months Ended
|
|
|
|
May 4,
2014
|
|
|
April 28,
2013
|
|
|
May 4,
2014
|
|
|
April 28,
2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
124,030
|
|
|
$
|
126,535
|
|
|
$
|
250,865
|
|
|
$
|
252,381
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
3,499
|
|
|
$
|
9,297
|
|
|
$
|
9,926
|
|
|
$
|
17,470
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to Photronics, Inc. shareholders
|
|
$
|
1,047
|
|
|
$
|
6,210
|
|
|
$
|
3,706
|
|
|
$
|
10,668
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share
|
|
$
|
0.02
|
|
|
$
|
0.10
|
|
|
$
|
0.06
|
|
|
$
|
0.17
|
|
NOTE 3 - CHANGES IN EQUITY
The following tables set forth the Company's consolidated changes in equity for the three and six month periods ended May 4, 2014 and April 28, 2013:
|
|
Three Months Ended May 4, 2014
|
|
|
|
Photronics, Inc. Shareholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
|
|
|
Amount
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at February 3, 2014
|
|
|
61,325
|
|
|
$
|
613
|
|
|
$
|
500,409
|
|
|
$
|
61,432
|
|
|
$
|
17,980
|
|
|
$
|
770
|
|
|
$
|
581,204
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
15,540
|
|
|
|
-
|
|
|
|
410
|
|
|
|
15,950
|
|
Other comprehensive income
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
11,628
|
|
|
|
34
|
|
|
|
11,662
|
|
Sale of common stock through employee stock option and purchase plans
|
|
|
66
|
|
|
|
1
|
|
|
|
282
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
283
|
|
Restricted stock awards vesting and expense
|
|
|
17
|
|
|
|
-
|
|
|
|
356
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
356
|
|
Share-based compensation expense
|
|
|
-
|
|
|
|
-
|
|
|
|
687
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
687
|
|
Acquisition of DPTT
|
|
|
-
|
|
|
|
-
|
|
|
|
(6,291
|
)
|
|
|
-
|
|
|
|
412
|
|
|
|
105,404
|
|
|
|
99,525
|
|
Redemption of common stock by subsidiary
|
|
|
-
|
|
|
|
-
|
|
|
|
73
|
|
|
|
-
|
|
|
|
(1
|
)
|
|
|
-
|
|
|
|
72
|
|
Balance at May 4, 2014
|
|
|
61,408
|
|
|
$
|
614
|
|
|
$
|
495,516
|
|
|
$
|
76,972
|
|
|
$
|
30,019
|
|
|
$
|
106,618
|
|
|
$
|
709,739
|
|
|
|
Three Months Ended April 28, 2013
|
|
|
|
Photronics, Inc. Shareholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
|
|
|
Amount
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 28, 2013
|
|
|
60,362
|
|
|
$
|
603
|
|
|
$
|
494,984
|
|
|
$
|
43,797
|
|
|
$
|
23,812
|
|
|
$
|
30,645
|
|
|
$
|
593,841
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
4,863
|
|
|
|
-
|
|
|
|
579
|
|
|
|
5,442
|
|
Other comprehensive loss
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(12,396
|
)
|
|
|
(662
|
)
|
|
|
(13,058
|
)
|
Sale of common stock through employee stock option and purchase plans
|
|
|
212
|
|
|
|
2
|
|
|
|
281
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
283
|
|
Restricted stock awards vesting and expense
|
|
|
24
|
|
|
|
1
|
|
|
|
340
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
341
|
|
Share-based compensation expense
|
|
|
-
|
|
|
|
-
|
|
|
|
599
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
599
|
|
Balance at April 28, 2013
|
|
|
60,598
|
|
|
$
|
606
|
|
|
$
|
496,204
|
|
|
$
|
48,660
|
|
|
$
|
11,416
|
|
|
$
|
30,562
|
|
|
$
|
587,448
|
|
|
|
Six Months Ended May 4, 2014
|
|
|
|
Photronics, Inc. Shareholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
|
|
|
Amount
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at November 4, 2013
|
|
|
61,083
|
|
|
$
|
611
|
|
|
$
|
498,861
|
|
|
$
|
59,439
|
|
|
$
|
26,403
|
|
|
$
|
2,517
|
|
|
$
|
587,831
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
17,533
|
|
|
|
-
|
|
|
|
459
|
|
|
|
17,992
|
|
Other comprehensive income (loss)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
3,217
|
|
|
|
(47
|
)
|
|
|
3,170
|
|
Sale of common stock through employee stock option and purchase plans
|
|
|
196
|
|
|
|
2
|
|
|
|
690
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
692
|
|
Restricted stock awards vesting and expense
|
|
|
129
|
|
|
|
1
|
|
|
|
564
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
565
|
|
Share-based compensation expense
|
|
|
-
|
|
|
|
-
|
|
|
|
1,583
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,583
|
|
Acquisition of DPTT
|
|
|
-
|
|
|
|
-
|
|
|
|
(6,291
|
)
|
|
|
-
|
|
|
|
412
|
|
|
|
105,404
|
|
|
|
99,525
|
|
Redemption of common stock by subsidiary
|
|
|
-
|
|
|
|
-
|
|
|
|
109
|
|
|
|
-
|
|
|
|
(13
|
)
|
|
|
(1,715
|
)
|
|
|
(1,619
|
)
|
Balance at May 4, 2014
|
|
|
61,408
|
|
|
$
|
614
|
|
|
$
|
495,516
|
|
|
$
|
76,972
|
|
|
$
|
30,019
|
|
|
$
|
106,618
|
|
|
$
|
709,739
|
|
|
|
Six Months Ended April 28, 2013
|
|
|
|
Photronics, Inc. Shareholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
|
|
|
Amount
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at October 29, 2012
|
|
|
60,213
|
|
|
$
|
602
|
|
|
$
|
493,411
|
|
|
$
|
41,473
|
|
|
$
|
15,900
|
|
|
$
|
34,615
|
|
|
$
|
586,001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
7,187
|
|
|
|
-
|
|
|
|
1,114
|
|
|
|
8,301
|
|
Other comprehensive loss
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(4,457
|
)
|
|
|
(432
|
)
|
|
|
(4,889
|
)
|
Sale of common stock through employee stock option and purchase plans
|
|
|
289
|
|
|
|
3
|
|
|
|
390
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
393
|
|
Restricted stock awards vesting and expense
|
|
|
96
|
|
|
|
1
|
|
|
|
610
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
611
|
|
Share-based compensation expense
|
|
|
-
|
|
|
|
-
|
|
|
|
1,214
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,214
|
|
Repurchase of common stock by subsidiary
|
|
|
-
|
|
|
|
-
|
|
|
|
579
|
|
|
|
-
|
|
|
|
(27
|
)
|
|
|
(4,735
|
)
|
|
|
(4,183
|
)
|
Balance at April 28, 2013
|
|
|
60,598
|
|
|
$
|
606
|
|
|
$
|
496,204
|
|
|
$
|
48,660
|
|
|
$
|
11,416
|
|
|
$
|
30,562
|
|
|
$
|
587,448
|
|
NOTE 4 - PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment consists of the following:
|
|
May 4,
2014
|
|
|
November 3,
2013
|
|
|
|
|
|
|
|
|
Land
|
|
$
|
8,797
|
|
|
$
|
8,692
|
|
Buildings and improvements
|
|
|
128,766
|
|
|
|
103,676
|
|
Machinery and equipment
|
|
|
1,354,470
|
|
|
|
1,225,091
|
|
Leasehold improvements
|
|
|
20,309
|
|
|
|
4,179
|
|
Furniture, fixtures and office equipment
|
|
|
12,196
|
|
|
|
11,546
|
|
Construction in progress
|
|
|
67,603
|
|
|
|
97,319
|
|
|
|
|
1,592,141
|
|
|
|
1,450,503
|
|
Less accumulated depreciation and amortization
|
|
|
1,058,076
|
|
|
|
1,027,763
|
|
|
|
$
|
534,065
|
|
|
$
|
422,740
|
|
Equipment under capital leases are included in above property, plant and equipment as follows:
|
|
May 4,
2014
|
|
|
November 3,
2013
|
|
|
|
|
|
|
|
|
Machinery and equipment
|
|
$
|
56,245
|
|
|
$
|
21,327
|
|
Construction in progress
|
|
|
-
|
|
|
|
34,918
|
|
|
|
|
56,245
|
|
|
|
56,245
|
|
Less accumulated amortization
|
|
|
7,618
|
|
|
|
4,932
|
|
|
|
$
|
48,627
|
|
|
$
|
51,313
|
|
Depreciation expense for property, plant and equipment (excluding equipment under capital leases) was $15.7 million and $30.4 million for the three and six month periods ended May 4, 2014, respectively, and $16.1 million and $33.1 million for the three and six month periods ended April 28, 2013, respectively. Amortization expense for equipment under capital leases was $1.4 million and $2.7 million for the three and six month periods ended May 4, 2014, respectively, and $0.5 million and $1.0 million for the three and six month periods ended April 28, 2013, respectively.
NOTE 5 - JOINT VENTURE, TECHNOLOGY LICENSE AND OTHER AGREEMENTS WITH MICRON TECHNOLOGY, INC.
In May 2006, Photronics and Micron Technology, Inc. ("Micron") entered into the MP Mask joint venture (“MP Mask”), which develops and produces photomasks for leading-edge and advanced next generation semiconductors. At the time of the formation of the joint venture, the Company also entered into both an agreement to license photomask technology developed by Micron and certain supply agreements.
This joint venture is a variable interest entity ("VIE") (as that term is defined in the ASC) because all costs of the joint venture are passed on to the Company and Micron through purchase agreements they have entered into with the joint venture, and it is dependent upon the Company and Micron for any additional cash requirements. On a quarterly basis the Company reassesses whether its interest in MP Mask gives it a controlling financial interest in this VIE. The purpose of this quarterly reassessment is to identify the primary beneficiary (which is defined in the ASC as the entity that consolidates a VIE) of the VIE. As a result of the reassessment in the current quarter, the Company determined that Micron is still the primary beneficiary of the VIE, by virtue of its tie-breaking voting rights within MP Mask’s Board of Managers, thereby giving it the power to direct the activities of MP Mask that most significantly impact its economic performance, including its decision making authority in the ordinary course of business and its purchasing the majority of products produced by the VIE.
The Company has utilized MP Mask for both high-end IC photomask production and research and development purposes. MP Mask charges its variable interest holders based on their actual usage of its facility. MP Mask separately charges for any research and development activities it engages in at the requests of its owners. The Company recorded cost of sales of $0.9 million and $1.9 million and research and development expenses of $0.2 million and $0.5 million during the three and six month periods ended May 4, 2014. Cost of sales of $3.5 million and $5.4 million and research and development expenses of $0.2 million and $0.5 million were recorded during the three and six month periods ended April 28, 2013. As of May 4, 2014 and November 3, 2013, the Company owed MP Mask $4.9 million and $4.5 million, respectively, and had a receivable from Micron of $6.4 million and $4.9 million, respectively, both primarily related to the aforementioned supply agreements.
MP Mask is governed by a Board of Managers, appointed by Micron and the Company. Since MP Mask's inception, Micron, as a result of its majority ownership, has held majority voting power on the Board of Managers. The voting power held by each party is subject to change as ownership interests change. Under the MP Mask joint venture operating agreement, the Company may be required to make additional capital contributions to MP Mask up to the maximum amount defined in the operating agreement. However, should the Board of Managers determine that further additional funding is required, MP Mask shall pursue its own financing. If MP Mask is unable to obtain its own financing, it may request additional capital contributions from the Company. Should the Company choose not to make a requested contribution to MP Mask, its ownership percentage may be reduced.
The Company's investment in the VIE, which represents its maximum exposure to loss, was $93.1 million at May 4, 2014 and November 3, 2013. These amounts are reported in the Company's condensed consolidated balance sheets as "Investment in joint venture". The Company recorded a loss from its investment in the VIE of $0.2 million in the six month period ended April 28, 2013, and recorded no income from its investment in the three month period ended April 28, 2013, or in the three or six month periods ended May 4, 2014. Income from the VIE is included in "Interest and other income (expense), net" in the condensed consolidated statements of income.
NOTE 6 - LONG-TERM BORROWINGS
Long-term borrowings consist of the following:
|
|
May 4,
2014
|
|
|
November 3,
2013
|
|
|
|
|
|
|
|
|
3.25% convertible senior notes due in April 2016
|
|
$
|
115,000
|
|
|
$
|
115,000
|
|
|
|
|
|
|
|
|
|
|
2.77% capital lease obligation payable through July 2018
|
|
|
22,996
|
|
|
|
25,065
|
|
|
|
|
|
|
|
|
|
|
5.50% convertible senior notes due in October 2014
|
|
|
22,054
|
|
|
|
22,054
|
|
|
|
|
|
|
|
|
|
|
3.09% capital lease obligation payable through March 2016
|
|
|
8,872
|
|
|
|
10,652
|
|
|
|
|
|
|
|
|
|
|
Term loan, which bore interest at a variable rate, as defined, repaid in December 2013
|
|
|
-
|
|
|
|
21,250
|
|
|
|
|
168,922
|
|
|
|
194,021
|
|
Less current portion
|
|
|
10,231
|
|
|
|
11,818
|
|
|
|
$
|
158,691
|
|
|
$
|
182,203
|
|
In December 2013 the Company amended its credit facility, increasing its limit to $50 million with an expansion capacity to $75 million, and extending its term to December 2018. Simultaneously, the Company repaid its $21.3 million term loan. The interest rate spread on borrowings has been reduced and the minimum fixed charge ratio has been replaced with a minimum interest coverage ratio under the terms of the amended credit facility which, in addition, increased the investment baskets (as defined in the credit facility) and continues to include total leverage ratio and minimum unrestricted cash balance covenants. The credit facility bears interest (1.94 percent at May 4, 2014) based on the Company’s total leverage ratio, at LIBOR plus a spread, as defined in the credit facility. As of May 4, 2014, the Company had no outstanding borrowings under the credit facility and $50 million was available for borrowing. The credit facility is secured by substantially all of the Company’s assets located in the United States, as well as common stock the Company owns in certain of its foreign subsidiaries.
In August 2013 a $26.4 million principal amount, five year capital lease commenced to fund the purchase of a high-end lithography tool. Payments under the capital lease, which bears interest at 2.77 percent, are $0.5 million per month through July 2018. Under the terms of the lease agreement, the Company must maintain the equipment in good working order, and is subject to a cross default with cross acceleration provision related to certain nonfinancial covenants incorporated in its credit facility. As of May 4, 2014, the total amount payable through the end of the lease term was $24.4 million, of which $23.0 million represented principal and $1.4 million represented interest.
In March 2012 the Company, in connection with its purchase of the U.S. nanoFab facility, amended its credit facility (“the credit facility”) to include the addition of a $25 million term loan that was to mature in March 2017. In December 2013, simultaneous with the amendment of its credit facility discussed above, the Company repaid the $21.3 million balance of this term loan that was outstanding at November 3, 2013.
In March 2011 the Company issued through a private offering pursuant to Rule 144A under the Securities Act of 1933, as amended, $115 million aggregate principal amount of 3.25% convertible senior notes. The notes mature on April 1, 2016, and note holders may convert each $1,000 principal amount of notes to approximately 96 shares of common stock (equivalent to an initial conversion price of $10.37 per share of common stock) at any time prior to the close of business on the second scheduled trading day immediately preceding April 1, 2016. The conversion rate is subject to adjustment upon the occurrence of certain events, which are described in the indenture dated March 28, 2011. The Company is not required to redeem the notes prior to their maturity date. Interest on the notes accrues in arrears, and is paid semiannually through the notes’ maturity date. The net proceeds of the notes were approximately $110.7 million, which were used, in part, to acquire $35.4 million of the Company’s 5.5% convertible senior notes which were to mature on October 1, 2014, and to repay, in full, its then outstanding obligations under capital leases of $19.8 million.
In September 2009 the Company issued, through a public offering, $57.5 million aggregate principal amount of 5.5% convertible senior notes, which were to mature on October 1, 2014. Under the terms of the offering, the note holders could convert each $1,000 principal amount of notes to approximately 197 shares of common stock (equivalent to an initial conversion price of $5.08 per share of common stock) on, or before, September 30, 2014. The conversion rate is subject to adjustment upon the occurrence of certain events which are described in the indenture dated September 16, 2009. The Company is not required to redeem the notes prior to their maturity. The net proceeds of this offering were approximately $54.9 million, which were used to reduce amounts outstanding under the Company’s credit facility. As discussed above, $35.4 million aggregate principal amount of these notes were acquired by the Company during fiscal 2011. The Company intends to repay the remaining outstanding 5.5% convertible senior notes due in October 2014 with borrowings against its credit facility and, therefore, has classified as long-term the entire $22.1 million of those notes that were outstanding as of May 4, 2014.
In April 2011 the Company entered into a five year, $21.2 million capital lease for manufacturing equipment. Payments under the lease, which bears interest at 3.09 percent, are $0.4 million per month through March 2016. The lease agreement provides that the Company must maintain the equipment in good working order, and includes a cross default with cross acceleration provision related to certain non-financial covenants incorporated in the Company's credit facility agreement. As of May 4, 2014, the total amount payable through the end of the lease term was $9.2 million, of which $8.9 million represented principal and $0.3 million represented interest.
NOTE 7 - COMMON STOCK WARRANTS
In September 2009 the Company entered into two warrant agreements with Intel Capital Corporation to purchase a total of 750,000 shares of the Company's common stock. Under one warrant agreement 500,000 shares of the Company's common stock could be purchased at an exercise price of $4.15 per share and under the second warrant agreement 250,000 shares of the Company's common stock could be purchased at an exercise price of $5.08 per share. The warrant agreements were to expire in September 2014. Also in September 2009, the Company and Intel Corporation entered into an agreement to share technical and operations information regarding the development of the Company's products, the capabilities of the Company's photomask manufacturing lines and the alignment of photomask toolsets. Intel Capital Corporation also invested in the Company's convertible debt offering of September 2009. The warrants were recorded at their fair value on their date of grant, which was determined using the Black-Scholes option pricing model. In June 2013 Intel Capital Corporation exercised all of the warrants under both warrant agreements on a net share basis and received 0.3 million shares of the Company’s common stock.
NOTE 8 - SHARE-BASED COMPENSATION
The Company has a share-based compensation plan ("Plan"), under which options, restricted stock, restricted stock units, stock appreciation rights, performance stock, performance units, and other awards based on, or related to, shares of the Company's common stock may be granted from shares authorized but unissued or shares previously issued and reacquired by the Company. The maximum number of shares of common stock approved by the Company’s shareholders to be issued under the Plan was increased from six million shares to nine million shares during the three month period ended May 4, 2014. Awards may be granted to officers, employees, directors, consultants, advisors, and independent contractors of the Company or its subsidiaries. In the event of a change in control (as defined in the Plan), the vesting of awards may be accelerated. The Plan, aspects of which are more fully described below, prohibits further awards from being issued under prior plans. Total share-based compensation costs for the three and six month periods ended May 4, 2014, were $1.0 million and $2.1 million, respectively, and $0.9 million and $1.8 million for the three and six month periods ended April 28, 2013, respectively. The Company received cash from option exercises of $0.3 million and $0.7 million for the three and six month periods ended May 4, 2014, respectively, and $0.3 million and $0.4 million for the three and six month periods ended April 28, 2013, respectively. No share-based compensation cost was capitalized as part of an asset and no related income tax benefits were recorded during the periods presented.
Stock Options
Option awards generally vest in one to four years, and have a ten-year contractual term. All incentive and non-qualified stock option grants have an exercise price equal to the market value of the underlying common stock on the date of grant. The grant date fair value of options are based on closing prices of the Company’s common stock on the dates of grant using the Black-Scholes option pricing model. Expected volatility is based on the historical volatility of the Company's stock. The Company uses historical option exercise behavior and employee termination data to estimate expected term, which represents the period of time that the options granted are expected to remain outstanding. The risk-free rate of return for the estimated term of the option is based on the U.S. Treasury yield curve in effect at the date of grant.
The weighted-average inputs and risk-free rate of return ranges used to calculate the grant date fair value of options issued during the three and six month periods ended May 4, 2014 and April 28, 2013, are presented in the following table.
|
|
Three Months Ended
|
|
|
Six Months Ended
|
|
|
|
May 4,
2014
|
|
|
April 28,
2013
|
|
|
May 4,
2014
|
|
|
April 28,
2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected volatility
|
|
|
N/A
|
|
|
|
84.5
|
%
|
|
|
61.1
|
%
|
|
|
99.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk free rate of return
|
|
|
N/A
|
|
|
|
0.6
|
%
|
|
|
1.4
|
%
|
|
|
0.5% - 0.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend yield
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected term
|
|
|
N/A
|
|
|
4.3 years
|
|
|
4.6 years
|
|
|
4.3 years
|
|
Information on outstanding and exercisable option awards as of May 4, 2014, is presented below.
Options
|
|
Shares
|
|
|
Weighted
Average
Exercise
Price
|
|
Weighted
Average
Remaining
Contractual
Life
|
|
Aggregate
Intrinsic
Value
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at May 4, 2014
|
|
|
4,501,114
|
|
|
$
|
8.59
|
|
5.8 years
|
|
$
|
10,548
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at May 4, 2014
|
|
|
3,021,073
|
|
|
$
|
9.27
|
|
4.3 years
|
|
$
|
8,183
|
|
There were no share options granted during the three month period ended May 4, 2014, and there were 20,000 share options granted during the three month period ended April 28, 2013, with a grant date fair value of $4.07 per share. There were 612,500 share options granted during the six month period ended May 4, 2014, with a weighted-average grant date fair value of $4.45 per share and 584,000 share options granted during the six month period ended April 28, 2013, with a weighted-average grant date fair value of $3.99 per share. As of May 4, 2014, the total unrecognized compensation cost related to unvested option awards was approximately $5.0 million. That cost is expected to be recognized over a weighted-average amortization period of 2.6 years.
Restricted Stock
The Company periodically grants restricted stock awards. The restrictions on these awards lapse over a service period that has ranged from less-than-one to eight years. No restricted stock awards were granted during the three month period ended May 4, 2014, and 111,667 restricted stock awards were issued during the six month period ended May 4, 2014, with a weighted-average grant date fair value of $8.86 per share. There were 5,000 restricted stock awards granted during the three month period ended April 28, 2013, with a weighted average grant date fair value of $6.43 per share, and 209,500 restricted stock awards granted during the six month period ended April 28, 2013, with a weighted-average grant date fair value of $5.48 per share. As of May 4, 2014, the total compensation cost not yet recognized related to unvested restricted stock awards was approximately $1.5 million. That cost is expected to be recognized over a weighted-average amortization period of 2.0 years. As of May 4, 2014, there were 278,419 shares of restricted stock outstanding.
NOTE 9 - INCOME TAXES
The effective income tax rates for the three month periods ended May 4, 2014 and April 28, 2013, differ from the rates computed by applying the U.S. statutory rate of 35% to income before income taxes for the periods primarily due to foreign tax rate differences, as well as the existence of valuation allowances in jurisdictions with historical and continuing tax losses.
Unrecognized tax benefits related to uncertain tax positions were $7.9 million at May 4, 2014 and $4.9 million at November 3, 2013, of which $4.7 million and $1.7 million, respectively, would favorably impact the Company’s effective tax rate if recognized. The current period increase is primarily due to uncertain tax positions related to the acquisition of DPTT (as discussed in Note 2), net of the recognition of a previously unrecognized benefit as a result of a lapse of an assessment period. Accrued interest and penalties related to unrecognized tax benefits was $0.1 million both at May 4, 2014 and November 3, 2013. As of May 4, 2014, the total amount of unrecognized tax benefits is not expected to significantly increase or decrease in the next twelve months.
During the three month period ended May 4, 2014, PSMC, in conjunction with the acquisition of DPTT, made a one-time remittance of $35.1 million of earnings previously considered to be permanently reinvested, as a result of ownership interest provisions in the acquisition agreements. The balance of the entity’s undistributed earnings remains indefinitely reinvested.
As a result of the acquisition of DPTT(as discussed in Note 2), the Company had an increase in available foreign tax operating loss carryforwards of approximately $57.6 million that expire between 2015 and 2018, the benefits of which are anticipated to be fully realized.
PKLT, the Company's FPD manufacturing facility in Taiwan, is accorded a tax holiday which commenced in 2012 and expires in 2017. The tax holiday had no dollar or per share effect in the three and six months ended May 4, 2014 and April 28, 2013.
NOTE 10 - EARNINGS PER SHARE
The calculation of basic and diluted earnings per share is presented below.
|
|
Three Months Ended
|
|
|
Six Months Ended
|
|
|
|
May 4,
2014
|
|
|
April 28,
2013
|
|
|
May 4,
2014
|
|
|
April 28,
2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to Photronics, Inc. shareholders
|
|
$
|
15,540
|
|
|
$
|
4,863
|
|
|
$
|
17,533
|
|
|
$
|
7,187
|
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense on convertible notes, net of related tax effects
|
|
|
1,542
|
|
|
|
-
|
|
|
|
3,084
|
|
|
|
-
|
|
Earnings for diluted earnings per share
|
|
$
|
17,082
|
|
|
$
|
4,863
|
|
|
$
|
20,617
|
|
|
$
|
7,187
|
|
Weighted-average common shares computations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares used for basic earnings per share
|
|
|
61,372
|
|
|
|
60,493
|
|
|
|
61,286
|
|
|
|
60,385
|
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible notes
|
|
|
15,423
|
|
|
|
-
|
|
|
|
15,423
|
|
|
|
-
|
|
Share-based payment awards
|
|
|
910
|
|
|
|
766
|
|
|
|
923
|
|
|
|
726
|
|
Common stock warrants
|
|
|
-
|
|
|
|
242
|
|
|
|
-
|
|
|
|
187
|
|
Potentially dilutive common shares
|
|
|
16,333
|
|
|
|
1,008
|
|
|
|
16,346
|
|
|
|
913
|
|
Weighted-average common shares used for diluted earnings per share
|
|
|
77,705
|
|
|
|
61,501
|
|
|
|
77,632
|
|
|
|
61,298
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share
|
|
$
|
0.25
|
|
|
$
|
0.08
|
|
|
$
|
0.29
|
|
|
$
|
0.12
|
|
Diluted earnings per share
|
|
$
|
0.22
|
|
|
$
|
0.08
|
|
|
$
|
0.27
|
|
|
$
|
0.12
|
|
The table below shows the outstanding weighted-average share-based payment awards that were excluded from the calculation of diluted earnings per share because their exercise price exceeded the average market value of the common shares for the period or, under application of the treasury stock method, they were otherwise determined to be anti-dilutive. The table also shows convertible notes that, if converted, would have been antidilutive.
|
|
Three Months Ended
|
|
|
Six Months Ended
|
|
|
|
May 4,
2014
|
|
|
April 28,
2013
|
|
|
May 4,
2014
|
|
|
April 28,
2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based payment awards
|
|
|
2,105
|
|
|
|
2,901
|
|
|
|
2,131
|
|
|
|
2,922
|
|
Convertible notes
|
|
|
-
|
|
|
|
15,423
|
|
|
|
-
|
|
|
|
15,423
|
|
Total potentially dilutive shares excluded
|
|
|
2,105
|
|
|
|
18,324
|
|
|
|
2,131
|
|
|
|
18,345
|
|
NOTE 11 - CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME BY COMPONENT
The following tables set forth the
changes in the Company's accumulated other comprehensive income by component (net of tax of $0)
for the three and six month periods ended May 4, 2014 and April 28, 2013:
|
|
Three Months Ended May 4, 2014
|
|
|
|
Foreign Currency
Translation
Adjustments
|
|
|
|
|
|
Other
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at February 3, 2014
|
|
$
|
19,326
|
|
|
$
|
(530
|
)
|
|
$
|
(816
|
)
|
|
$
|
17,980
|
|
Other comprehensive income (loss) before reclassifications
|
|
|
11,635
|
|
|
|
-
|
|
|
|
(5
|
)
|
|
|
11,630
|
|
Amounts reclassified from other comprehensive income
|
|
|
-
|
|
|
|
32
|
|
|
|
-
|
|
|
|
32
|
|
Net current period other comprehensive income (loss)
|
|
|
11,635
|
|
|
|
32
|
|
|
|
(5
|
)
|
|
|
11,662
|
|
Other comprehensive income allocated to noncontrolling interests
|
|
|
-
|
|
|
|
-
|
|
|
|
412
|
|
|
|
412
|
|
Less: other comprehensive income attributable to noncontrolling interests
|
|
|
(33
|
)
|
|
|
-
|
|
|
|
(2
|
)
|
|
|
(35
|
)
|
Balance at May 4, 2014
|
|
$
|
30,928
|
|
|
$
|
(498
|
)
|
|
$
|
(411
|
)
|
|
$
|
30,019
|
|
|
|
Three Months Ended April 28, 2013
|
|
|
|
Foreign Currency
Translation
Adjustments
|
|
|
|
|
|
Other
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 28, 2013
|
|
$
|
25,152
|
|
|
$
|
(658
|
)
|
|
$
|
(682
|
)
|
|
$
|
23,812
|
|
Other comprehensive income (loss) before reclassifications
|
|
|
(13,104
|
)
|
|
|
-
|
|
|
|
14
|
|
|
|
(13,090
|
)
|
Amounts reclassified from other comprehensive income
|
|
|
-
|
|
|
|
32
|
|
|
|
-
|
|
|
|
32
|
|
Net current period other comprehensive income (loss)
|
|
|
(13,104
|
)
|
|
|
32
|
|
|
|
14
|
|
|
|
(13,058
|
)
|
Less: other comprehensive loss attributable to noncontrolling interests
|
|
|
662
|
|
|
|
-
|
|
|
|
-
|
|
|
|
662
|
|
Balance at April 28, 2013
|
|
$
|
12,710
|
|
|
$
|
(626
|
)
|
|
$
|
(668
|
)
|
|
$
|
11,416
|
|
|
|
Six Months Ended May 4, 2014
|
|
|
|
Foreign Currency
Translation
Adjustments
|
|
|
|
|
|
Other
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at November 4, 2013
|
|
$
|
27,797
|
|
|
$
|
(562
|
)
|
|
$
|
(832
|
)
|
|
$
|
26,403
|
|
Other comprehensive income before reclassifications
|
|
|
3,084
|
|
|
|
-
|
|
|
|
22
|
|
|
|
3,106
|
|
Amounts reclassified from other comprehensive income
|
|
|
-
|
|
|
|
64
|
|
|
|
-
|
|
|
|
64
|
|
Net current period other comprehensive income
|
|
|
3,084
|
|
|
|
64
|
|
|
|
22
|
|
|
|
3,170
|
|
Less: other comprehensive income attributable to noncontrolling interests
|
|
|
47
|
|
|
|
-
|
|
|
|
-
|
|
|
|
47
|
|
Other comprehensive income allocated to noncontrolling interests
|
|
|
-
|
|
|
|
-
|
|
|
|
412
|
|
|
|
412
|
|
Redemption of common stock by subsidiary
|
|
|
-
|
|
|
|
-
|
|
|
|
(13
|
)
|
|
|
(13
|
)
|
Balance at May 4, 2014
|
|
$
|
30,928
|
|
|
$
|
(498
|
)
|
|
$
|
(411
|
)
|
|
$
|
30,019
|
|
|
|
Six Months Ended April 28, 2013
|
|
|
|
Foreign Currency
Translation
Adjustments
|
|
|
|
|
|
Other
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at October 29, 2012
|
|
$
|
17,241
|
|
|
$
|
(690
|
)
|
|
$
|
(651
|
)
|
|
$
|
15,900
|
|
Other comprehensive income (loss) before reclassifications
|
|
|
(4,963
|
)
|
|
|
-
|
|
|
|
10
|
|
|
|
(4,953
|
)
|
Amounts reclassified from other comprehensive income
|
|
|
-
|
|
|
|
64
|
|
|
|
-
|
|
|
|
64
|
|
Net current period other comprehensive income (loss)
|
|
|
(4,963
|
)
|
|
|
64
|
|
|
|
10
|
|
|
|
(4,889
|
)
|
Less: other comprehensive loss attributable to noncontrolling interests
|
|
|
432
|
|
|
|
-
|
|
|
|
-
|
|
|
|
432
|
|
Repurchase of common stock by subsidiary
|
|
|
-
|
|
|
|
-
|
|
|
|
(27
|
)
|
|
|
(27
|
)
|
Balance at April 28, 2013
|
|
$
|
12,710
|
|
|
$
|
(626
|
)
|
|
$
|
(668
|
)
|
|
$
|
11,416
|
|
The amortization of the cash flow hedge is included in cost of sales in the condensed consolidated statements of income for all periods presented.
NOTE 12 – GEOGRAPHIC INFORMATION
The Company operates as a single operating segment as a manufacturer of photomasks, which are high precision quartz plates containing microscopic images of electronic circuits for use in the fabrication of ICs and FPDs. Geographic net sales are based primarily on where the Company's manufacturing facility is located.
The Company's net sales by geographic area and for ICs and FPDs for the three and six month periods ended May 4, 2014 and April 28, 2013, and its long-lived assets by geographic area as of May 4, 2014 and November 3, 2013, are presented below.
|
|
Three Months Ended
|
|
|
Six Months Ended
|
|
|
|
May 4,
2014
|
|
|
April 28,
2013
|
|
|
May 4,
2014
|
|
|
April 28,
2013
|
|
Net sales
|
|
|
|
|
|
|
|
|
|
|
|
|
Taiwan
|
|
$
|
35,764
|
|
|
$
|
27,425
|
|
|
$
|
64,941
|
|
|
$
|
55,819
|
|
Korea
|
|
|
32,790
|
|
|
|
32,332
|
|
|
|
69,607
|
|
|
|
66,304
|
|
United States
|
|
|
25,555
|
|
|
|
37,045
|
|
|
|
50,708
|
|
|
|
65,265
|
|
Europe
|
|
|
10,241
|
|
|
|
9,388
|
|
|
|
20,117
|
|
|
|
17,988
|
|
All other
|
|
|
532
|
|
|
|
490
|
|
|
|
1,051
|
|
|
|
1,143
|
|
|
|
$
|
104,882
|
|
|
$
|
106,680
|
|
|
$
|
206,424
|
|
|
$
|
206,519
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IC
|
|
$
|
76,547
|
|
|
$
|
82,164
|
|
|
$
|
152,760
|
|
|
$
|
156,588
|
|
FPD
|
|
|
28,335
|
|
|
|
24,516
|
|
|
|
53,664
|
|
|
|
49,931
|
|
|
|
$
|
104,882
|
|
|
$
|
106,680
|
|
|
$
|
206,424
|
|
|
$
|
206,519
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
|
|
|
|
|
|
|
|
|
|
May 4,
2014
|
|
|
November 3,
2013
|
|
|
|
|
|
|
|
|
|
Long-lived assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
189,307
|
|
|
$
|
191,518
|
|
|
|
|
|
|
|
|
|
Korea
|
|
|
172,030
|
|
|
|
153,878
|
|
|
|
|
|
|
|
|
|
Taiwan
|
|
|
162,886
|
|
|
|
66,836
|
|
|
|
|
|
|
|
|
|
Europe
|
|
|
9,815
|
|
|
|
10,471
|
|
|
|
|
|
|
|
|
|
All other
|
|
|
27
|
|
|
|
37
|
|
|
|
|
|
|
|
|
|
|
|
$
|
534,065
|
|
|
$
|
422,740
|
|
|
|
|
|
|
|
|
|
The Company is typically impacted during its first fiscal quarter by the North American and European holiday periods, as some customers reduce their effective workdays and orders during these periods. Additionally, the Company can be impacted during its first or second quarter by the Asian New Year holiday period, which may also reduce customer orders.
NOTE 13 - FAIR VALUE MEASUREMENTS
The accounting framework for determining fair value includes a hierarchy for ranking the quality and reliability of the information used to measure fair value, which enables the reader of the financial statements to assess the inputs used to develop those measurements. The fair value hierarchy consists of three tiers as follows: Level 1, defined as quoted market prices in active markets for identical securities; Level 2, defined as inputs other than Level 1 that are observable, either directly or indirectly; and Level 3, defined as unobservable inputs that are not corroborated by market data.
The Company did not have any assets or liabilities measured at fair value on a recurring basis at May 4, 2014 or November 3, 2013. During the three month period ended May 4, 2014, the Company measured and recorded the net assets it acquired in its subsidiary’s acquisition of DNP Photomask Technology Taiwan Co., Ltd. at fair value. See Note 2 for further information.
Fair Value of Other Financial Instruments
The fair values of the Company's cash and cash equivalents (Level 1 measurements), accounts receivable, accounts payable, and certain other current assets and current liabilities (Level 2 measurements) approximate their carrying value due to their short-term maturities. The fair value of the Company's variable rate term loan that was repaid in December 2013 is a Level 2 measurement and approximates its carrying value due to the variable nature of the underlying interest rates. The fair value of the Company's convertible senior notes is a Level 2 measurement that is determined using recent bid prices.
The table below presents the fair and carrying values of the Company's convertible senior notes at May 4, 2014 and November 3, 2013.
|
|
May 4, 2014
|
|
|
November 3, 2013
|
|
|
|
Fair Value
|
|
|
Carrying Value
|
|
|
Fair Value
|
|
|
Carrying Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.25% convertible senior notes
|
|
$
|
127,719
|
|
|
$
|
115,000
|
|
|
$
|
130,330
|
|
|
$
|
115,000
|
|
5.5% convertible senior notes
|
|
$
|
38,810
|
|
|
$
|
22,054
|
|
|
$
|
37,567
|
|
|
$
|
22,054
|
|
NOTE 14 - SUBSIDIARY SHARE REPURCHASE AND TENDER OFFER
Since the second quarter of fiscal 2011, the board of directors of PSMC, a subsidiary of the Company based in Taiwan, has authorized several share repurchase programs for PSMC to purchase for retirement shares of its outstanding common stock. The last of these repurchase programs concluded in the first fiscal quarter of 2013 in which PSMC purchased 9.2 million shares at a cost of $4.2 million. These repurchase programs increased the Company's ownership in PSMC from 72.09% at October 28, 2012, to 75.11% at January 27, 2013. During fiscal 2013 the Company increased its ownership interest in PSMC, primarily through a tender offer, to 98.63% by purchasing 51.4 million shares at a cost of $28.1 million. In January 2014 the Company increased its ownership percentage in PSMC to 100% at a cost of $1.7 million for the then remaining 3.0 million shares that were not owned by the Company.
In April 2014 DPTT merged into PSMC. See Note 2 for further discussion relating to the DPTT Acquisition.
The table below presents the effect of the change in the Company’s ownership interest in PDMC on the Company's equity for the three and six month periods ended May 4, 2014, (3.0 million shares of common stock acquired and 112.9 million shares of common stock issued, respectively) and the six month period ended April 28, 2013 (9.2 million shares of PSMC common stock acquired).
|
|
Three Months Ended
|
|
|
Six Months Ended
|
|
|
|
May 4,
2014
|
|
|
April 28,
2013
|
|
|
May 4,
2014
|
|
|
April 28,
2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to Photronics, Inc. shareholders
|
|
$
|
15,540
|
|
|
$
|
4,863
|
|
|
$
|
17,533
|
|
|
$
|
7,187
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) in Photronics, Inc.'s additional paid-in capital
|
|
|
(6,218
|
)
|
|
|
-
|
|
|
|
(6,182
|
)
|
|
|
579
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) in accumulated other comprehensive income
|
|
|
411
|
|
|
|
-
|
|
|
|
399
|
|
|
|
(27
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change from net income attributable to Photronics, Inc. shareholders due to issuance of shares of PDMC and transfers to and from noncontrolling interest
|
|
$
|
9,733
|
|
|
$
|
4,863
|
|
|
$
|
11,750
|
|
|
$
|
7,739
|
|
NOTE 15 - COMMITMENTS AND CONTINGENCIES
As of May 4, 2014, the Company had commitments outstanding for capital expenditures of approximately $74 million.
The Company is subject to various claims that arise in the ordinary course of business. The Company believes such claims, individually or in the aggregate, will not have a material effect on its condensed consolidated financial statements.
NOTE 16 - RECENT ACCOUNTING PRONOUNCEMENTS
There have been no recent accounting pronouncements whose adoption would affect the Company’s financial statements or related disclosures.